Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0002069951-26-000004

Options or other derivatives

  • Chief Corp Development Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cote Elissa S. Chief Corp Development Officer 2026-04-07 Grant or award · Incentive Stock Option (right to buy) +75,000 75,000 D: show line 1 in the form
Loading xslF345X06/edgardoc.xml…